The London-listed mixer-maker said Molson Coors would acquire an 8.5% shareholding in Fevertree.

Citi upgraded Molson Coors (TAP) to Neutral from Sell with a price target of $57, up from $47. The firm says its fundamental thesis has largely ...

Starting February 1, 2025, Molson Coors will assume exclusive commercialization rights to Fever-Tree’s award-winning lineup of tonics, ginger beers, cocktail mixers and more in the U.S. and will ...

Molson Coors Beverage Company has announced a strategic partnership with Fever-Tree in the US, aiming to fuel its premiumisation and ‘Beyond Beer’ strategies. Through the deal, Molson Coors ...

CHICAGO, January 30, 2025--(BUSINESS WIRE)--Molson Coors Beverage Company ("Molson Coors" or "the company") (NYSE: TAP, TAP.A) is expanding its U.S. non-alc portfolio through a new strategic ...

Starting on 1 February, Molson Coors will assume exclusive commercialization rights to Fever-Tree’s US portfolio, encompassing a lineup of tonics, ginger beers, cocktail mixers, and other carbonated ...

There is a price that comes with success. Mark Hamill can’t get a bagel without someone yelling “Luke, I AM your father.” Kit Harington suffers endless recitations of “You know nothing, John Snow.” ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike. Many investors also have a go-to methodology that helps guide their buy ...

Molson Coors aims to leverage Fever-Tree’s strong presence in the U.S. by utilizing its extensive distribution capabilities and commercial reach. The company’s “Beyond Beer” strategy has ...